ClinicalTrials.Veeva

Menu

Pivotal Response Treatment Package for Young Children With Autism (PRT-P)

Stanford University logo

Stanford University

Status

Completed

Conditions

Autism Spectrum Disorder (ASD)
Autism

Treatments

Behavioral: Pivotal Response Treatment Package (PRT-P)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02037022
IRB-28314
R21DC013689 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism.

Full description

Researchers at the Stanford University School of Medicine are seeking participants for a research study examining the effectiveness of a pivotal response treatment package (PRT-P) in targeting language skills in young children with autism. Research has demonstrated that behavioral interventions, such as Pivotal Response Training (PRT), lead to improvements in the core symptoms of autism. Researchers have begun to develop strategies to investigate the effectiveness of combining a parent training program teaching parents how to implement PRT with in-home, therapist-implemented treatment. To determine the effectiveness of a PRT-P, it will be compared to a delayed treatment group (DTG) by conducting a randomized controlled 24-week trial. This research will allow us to help in the development of therapeutic approaches that can meet the increasing service demands for families. We hope that investigating interventions that aim to improve core deficits will aid clinicians in providing better care for children with autism.

Enrollment

48 patients

Sex

All

Ages

2 to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of Autism Spectrum Disorder (ASD) based on Autism Diagnostic Interview- Revised (ADI-R), Autism Diagnostic Observation Schedule (ADOS-2), and expert clinical opinion
  • Males and females in good medical health between 2.0 and 5.11 years
  • Ability to participate in the testing procedures to the extent that valid standard scores can be obtained
  • Language delay as measured by the Preschool Language Scale: Standard score at least 1 Standard Deviation below average for expressive language ability
  • Stable treatment, speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation
  • No more than 60 minutes of individual 1:1 speech therapy per week
  • Availability of at least one parent who can consistently participate in parent training and research measures
  • Parents intend on continuing Pivotal Response Treatment Package (PRT-P) for a minimum of 12 weeks
  • Parents must be 18 years of age or older

Exclusion criteria

  • Current or lifetime diagnosis of severe psychiatric disorder, such as bipolar disorder
  • Receiving in-home Applied Behavior Analysis (ABA) of 10 hours or more
  • A genetic abnormality, such as Fragile X
  • Presence of active medical problem, such as unstable seizure disorder or heart disease
  • Previous adequate PRT trial
  • Participants living more than 50 miles from Stanford University
  • At least one room of the house must be available to be dedicated to treatment during session times
  • There must be no serious health and safety risks present in the home environment
  • The research team has the right to refuse to perform sessions in-home even if the criteria above are met

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

48 participants in 2 patient groups

Pivotal Response Treatment Package
Experimental group
Description:
Pivotal Response Treatment Package (PRT-P)
Treatment:
Behavioral: Pivotal Response Treatment Package (PRT-P)
Delayed Treatment Group
No Intervention group
Description:
Delayed Treatment Group (DTG)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems